Evidence map›Paper›PMID 34331177›Full record

ArticleAIDS and behavior2022

Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment.

Margaret M Paschen-Wolff, Aimee N C Campbell, Susan Tross, Tse-Hwei Choo, Martina Pavlicova, Sarah Braunstein, Rachael Lazar, Christine Borges, Michael Castro, Hayley Berg and 3 more

Open access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Overamped: Stimulant Use and HIV Pathogenesis.Current HIV/AIDS reports · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Margaret M Paschen-WolffDepartment of Psychiatry, Division On Substance Use Disorders, Columbia University Irving Medical Center At New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA. margaret.paschen-wolff@nyspi.columbia.edu.ORCID http://orcid.org/0000-0003-1176-5183
Aimee N C CampbellDepartment of Psychiatry, Division On Substance Use Disorders, Columbia University Irving Medical Center At New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032, USA.
Susan TrossHIV Center for Clinical and Behavioral Studies, Department of Psychiatry, Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA.
Tse-Hwei ChooMental Health Data Science Division, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, New York, NY, USA.
Martina PavlicovaDepartment of Biostatistics, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY, USA.
Sarah BraunsteinBureau of HIV Prevention and Control, New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, USA.
Rachael LazarBureau of HIV Prevention and Control, New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, USA.
Christine BorgesBureau of Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, USA.
Michael CastroBureau of Sexually Transmitted Infections, New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, USA.
Hayley BergSchool of Global Public Health, New York University, 665 Broadway, New York, NY, USA.
Graham HarrimanBureau of HIV Prevention and Control, New York City Department of Health and Mental Hygiene, 42-09 28th Street, Long Island City, NY, USA.
Robert H RemienHIV Center for Clinical and Behavioral Studies, Department of Psychiatry, Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University, New York, NY, USA.
Don Des JarlaisSchool of Global Public Health, New York University, 665 Broadway, New York, NY, USA.
New York City Department of Health and Mental Hygiene · USNew York Psychoanalytic Society and Institute · USColumbia University · USNew York University · USColumbia University Irving Medical Center · US

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan, Courtney McKnight · 1998 to 2026
$38.9M
Risk Factors for HIV/AIDS in Drug UsersR01DA003574 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C, MCKNIGHT, COURTNEY · 1986 to 2025
$16.2M
INSPIRE : Interdisciplinary Social and Behavioral Science Prevention and Intervention REsearch in HIVT32MH019139 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Claude Ann Mellins, Jae M. Sevelius · 1989 to 2026
$10.8M
Evaluating ART for All HIV Seropositives: Can it work with the hardest cases?R01DA035707 · NIDA · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI CAMPBELL, AIMEE N, DES JARLAIS, DON C · 2013 to 2017
$3.1M
NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA003574NIDA NIH HHS R01 DA035707NIMH NIH HHS P30 MH043520NIMH NIH HHS T32 MH019139
6 · The paper itself

Abstract

This study explored factors associated with durable viral suppression (DVS) among two groups of people living with HIV (PLWH) and problem substance use in the context of universal antiretroviral treatment initiation. Participants (N = 99) were recruited between 2014-2017 from public sexual health clinics [SHC] and a hospital detoxification unit [detox]). DVS (NYC HIV surveillance registry) was defined as two consecutive viral load tests ≤ 200 copies/mL, ≤ 90 days apart, with all other viral loads suppressed over 12 or 18 months. Detox participants were significantly older, with more unstable housing/employment, substance use severity, and longer-term HIV vs. SHC participants. Older age, opioid and stimulant use disorder were significantly associated with lower odds of DVS, while fulltime employment and stable housing were significantly associated with higher odds of DVS at 12-month follow-up. Patterns held at 18-month follow-up. Co-located substance use and HIV services, funding for supportive housing, and collaborative patient-provider relationships could improve DVS among populations with the syndemic of problem substance use, poverty, and long-term HIV.

Indexed as

HIV InfectionsSubstance-Related DisordersAgedAnti-Retroviral AgentsHumansSyndemicViral LoadAnti-Retroviral AgentsAdherenceAntiretroviral therapyHIV/AIDSSubstance useViral load

Identifiers

PMID34331177
PMCPMC8800950
OpenAlexW3184304332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.